264 related articles for article (PubMed ID: 31419586)
1. Role of retinal pigment epithelium permeability in drug transfer between posterior eye segment and systemic blood circulation.
Ramsay E; Hagström M; Vellonen KS; Boman S; Toropainen E; Del Amo EM; Kidron H; Urtti A; Ruponen M
Eur J Pharm Biopharm; 2019 Oct; 143():18-23. PubMed ID: 31419586
[TBL] [Abstract][Full Text] [Related]
2. Barrier analysis of periocular drug delivery to the posterior segment.
Ranta VP; Mannermaa E; Lummepuro K; Subrizi A; Laukkanen A; Antopolsky M; Murtomäki L; Hornof M; Urtti A
J Control Release; 2010 Nov; 148(1):42-48. PubMed ID: 20831888
[TBL] [Abstract][Full Text] [Related]
3. Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration.
Amrite AC; Edelhauser HF; Singh SR; Kompella UB
Mol Vis; 2008 Jan; 14():150-60. PubMed ID: 18334929
[TBL] [Abstract][Full Text] [Related]
4. Ocular Pharmacokinetics of Therapeutic Antibodies Given by Intravitreal Injection: Estimation of Retinal Permeabilities Using a 3-Compartment Semi-Mechanistic Model.
Hutton-Smith LA; Gaffney EA; Byrne HM; Maini PK; Gadkar K; Mazer NA
Mol Pharm; 2017 Aug; 14(8):2690-2696. PubMed ID: 28631484
[TBL] [Abstract][Full Text] [Related]
5. Movement of fluorescein and its glucuronide across retinal pigment epithelium-choroid.
Koyano S; Araie M; Eguchi S
Invest Ophthalmol Vis Sci; 1993 Mar; 34(3):531-8. PubMed ID: 8449674
[TBL] [Abstract][Full Text] [Related]
6. Characterization of brimonidine transport in retinal pigment epithelium.
Zhang N; Kannan R; Okamoto CT; Ryan SJ; Lee VH; Hinton DR
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):287-94. PubMed ID: 16384975
[TBL] [Abstract][Full Text] [Related]
7. Filter-cultured ARPE-19 cells as outer blood-retinal barrier model.
Mannermaa E; Reinisalo M; Ranta VP; Vellonen KS; Kokki H; Saarikko A; Kaarniranta K; Urtti A
Eur J Pharm Sci; 2010 Jul; 40(4):289-96. PubMed ID: 20385230
[TBL] [Abstract][Full Text] [Related]
8. Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity.
Pitkänen L; Ranta VP; Moilanen H; Urtti A
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):641-6. PubMed ID: 15671294
[TBL] [Abstract][Full Text] [Related]
9. Comparison of barrier properties of outer blood-retinal barrier models - Human stem cell-based models as a novel tool for ocular drug discovery.
Hellinen L; Hongisto H; Ramsay E; Kaarniranta K; Vellonen KS; Skottman H; Ruponen M
Eur J Pharm Biopharm; 2023 Mar; 184():181-188. PubMed ID: 36740104
[TBL] [Abstract][Full Text] [Related]
10. Measurement of retinal permeability to sodium fluorescein in vitro.
Tsuboi S; Fujimoto T; Uchihori Y; Emi K; Iizuka S; Kishida K; Manabe R
Invest Ophthalmol Vis Sci; 1984 Oct; 25(10):1146-50. PubMed ID: 6480293
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of transport of fluorescein across the isolated retinal pigment epithelium-choroid using an ussing type chamber].
Koyano S; Eguchi S; Araie M
Nippon Ganka Gakkai Zasshi; 1991 May; 95(5):434-40. PubMed ID: 1872214
[TBL] [Abstract][Full Text] [Related]
12. Effect of acute and chronic aldosterone exposure on the retinal pigment epithelium-choroid complex in rodents.
Canonica J; Mehanna C; Bonnard B; Jonet L; Gelize E; Jais JP; Jaisser F; Zhao M; Behar-Cohen F
Exp Eye Res; 2019 Oct; 187():107747. PubMed ID: 31394103
[TBL] [Abstract][Full Text] [Related]
13. Three-Dimensional Transport Model for Intravitreal and Suprachoroidal Drug Injection.
Zhang Y; Bazzazi H; Lima E Silva R; Pandey NB; Green JJ; Campochiaro PA; Popel AS
Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):5266-5276. PubMed ID: 30383198
[TBL] [Abstract][Full Text] [Related]
14. Ocular pharmacokinetics of intravitreally administered brimonidine and dexamethasone in animal models with and without blood-retinal barrier breakdown.
Shen J; Durairaj C; Lin T; Liu Y; Burke J
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):1056-66. PubMed ID: 24448267
[TBL] [Abstract][Full Text] [Related]
15. Relative permeability of retina and retinal pigment epithelium to the diffusion of tritiated water from vitreous to choroid.
Orr G; Goodnight R; Lean JS
Arch Ophthalmol; 1986 Nov; 104(11):1678-80. PubMed ID: 3778287
[TBL] [Abstract][Full Text] [Related]
16. Movement of carboxyfluorescein across retinal pigment epithelium-choroid.
Kimura M; Araie M; Koyano S
Exp Eye Res; 1996 Jul; 63(1):51-6. PubMed ID: 8983963
[TBL] [Abstract][Full Text] [Related]
17. Suprachoroidal delivery in a rabbit ex vivo eye model: influence of drug properties, regional differences in delivery, and comparison with intravitreal and intracameral routes.
Kadam RS; Williams J; Tyagi P; Edelhauser HF; Kompella UB
Mol Vis; 2013; 19():1198-210. PubMed ID: 23734089
[TBL] [Abstract][Full Text] [Related]
18. Permeability of the isolated dog retinal pigment epithelium to carboxyfluorescein.
Tsuboi S; Pederson JE
Invest Ophthalmol Vis Sci; 1986 Dec; 27(12):1767-70. PubMed ID: 3793409
[TBL] [Abstract][Full Text] [Related]
19. Effect of eye pigmentation on transscleral drug delivery.
Cheruvu NP; Amrite AC; Kompella UB
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):333-41. PubMed ID: 18172110
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of an ex vivo model implication for carrier-mediated retinal drug delivery.
Kansara V; Mitra AK
Curr Eye Res; 2006 May; 31(5):415-26. PubMed ID: 16714233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
